Dr. Arman Serebrakian, MD

Dr. Serebrakian practices at Marin Specialty Surgery Center in Greenbrae, California.

Dr. Serebrakian's NPI, 1184086407, was assigned on March 25, 2016. Dr. Serebrakian graduated from Lewis Katz School of Medicine in 2015. Dr. Serebrakian's California license number on file is A166296.

Dr. Serebrakian's primary practice is Marin Specialty Surgery Center, at 505 Sir Francis Drake Blvd, Greenbrae, CA 94904 in Marin County. The practice phone is (415) 461-4400.

Dr. Serebrakian's primary practice is Marin Specialty Surgery Center in Greenbrae, California. Dr. Serebrakian is also affiliated with MarinHealth Medical Center. The medical group on file is UCSF Medical Group. Dmand AI also links Dr. Serebrakian to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Serebrakian practices, 3 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Serebrakian's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dr. Serebrakian is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Serebrakian's licenses on file in 2 states: California and Massachusetts.

CMS data shows 1,191 Medicare services from Dr. Serebrakian across 13 procedure codes in 2024, for 422 Medicare patients. Medicare paid $93,071 for them.

CMS counts 422 Medicare patients who saw Dr. Serebrakian in 2024. The largest group is 65 to 74, with 180 patients. 75% of them have high cholesterol, and 65% have arthritis. 14% are also on Medicaid. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Serebrakian's median patient age at 64, with 56% women.

In 2024, Dr. Serebrakian wrote 26 Medicare Part D claims for 18 patients. 88% of them were for generic drugs. They cover 2 drugs, with $330 in total drug cost. In 2022, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Serebrakian for performance year 2024. CMS lists Dr. Serebrakian as offering telehealth.

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 21 papers to Dr. Serebrakian, published from 2013 to 2025. 2020 was the busiest year, with 4. The most frequent topics are Plastic Surgery Procedures. Dr. Serebrakian has published most often in Hand (N Y). Dr. Serebrakian's most frequent co-authors are Kyle R. Eberlin, MD, William Gerald Austen, MD and Arun Gosain, MD.

CMS Open Payments shows 77 general payments to Dr. Serebrakian from 18 drug and device companies from 2022 to 2025. Travel and lodging make up the largest share, 63% of the total. TriMed, Inc. paid the most, $1,853.

Dr. Serebrakian graduated from Lewis Katz School of Medicine in 2015.

Dr. Serebrakian is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.